In a study by He and colleagues, single-cell analysis of advanced PCa patients treated with ADT revealed the co-expression of multiple AR isoforms, with resistance to therapy associated with upregulation of EMT and TGF-β gene signatures [121]. The gene discussed is AR; the disease is posterior cortical atrophy.